-

EPSi Releases Covid-19 Planning Analytics Tool

Designed and created for health systems to dynamically forecast and plan for local market COVID-19 conditions leveraging national, state, and county level data along with advanced analytic techniques.

CHICAGO--(BUSINESS WIRE)--EPSi, Allscripts’ (NASDAQ: MDRX) flagship budgeting, planning/forecasting, cost accounting and financial decision support platform, announced the release of its COVID-19 Planning Analytics tool. Initially, the tool will be made available to EPSi’s 1,000+ hospital clients at no cost. The COVID-19 Planning Analytics tool includes five independent analyses focused on answering the tough questions being asked by health system leaders across the country – When will we run out of ICU capacity? What is the financial burden of COVID and how does this change with duration? When can I resume elective procedures? How much do I need to reduce costs in my remaining budget to return to baseline?

“When we heard that many of our clients were struggling trying to respond to the unprecedented challenges they faced with the COVID-19 pandemic, we partnered with a group of strategic finance and operations leaders in our client base to discuss their analytic requirements and quickly realized there were no off the shelf products that met their needs,” said Ralph Keiser, CEO of EPSi. “Through several weeks of interactive discussion and design, our team created a series of analytic dashboards to enable users to model the impact of COVID-19 to their patient population, as well as the financial and operational impact to their organization.”

“In partnership with our clients, we rapidly designed and rolled out several iterations of the tool,” said Ryan Self, Vice President of Professional Services at EPSi. “The first version we released focuses on 5 key themes:

  • Current Market Insights Provides state and county level detail into current COVID-19 cases and deaths, changes over time, and frequency indexed by populous. Also enables the ability to compare growth rates between states, normalized to ‘Day 1’ along with analyze volume and growth rate changes based upon various time periods.
  • Case Projections Leverage multiple forecasting techniques to model out COVID-19 cases, admissions, and patient days by accommodation code. Compare results against bed capacity to determine shortages by accommodation code along with anticipated dates in which capacity is restored to backfill the beds and begin the road to revenue recovery.
  • Financial Planning – Project out daily NPSR, cash, expense burn, and ultimately margin for insights into the financial impacts and ramifications of COVID-19 cases.
  • Operational Planning – Similarly, project out daily staffing, vent, and PPE needs to ensure adequate planning and resource availability before the surge.
  • Arc of the Possible – Study the ‘Arc of the Possible’ to understand the effort required to bring the health system back to financial recovery and the appropriate balance of energy between expense reduction with margin growth efforts.”

“The EPSi COVID-19 Planning Analytics tool is available at no cost to EPSi clients for the next 90 days through generous sponsorships by our partners at AWS and Tableau, who have underwritten the cost of the technology,” said Keiser. All EPSi Clients may access the tool by registering at https://epsi.io/go/covid-19-analytics/

About EPSi EPSi is the industry leader in integrated healthcare decision analytics, budgeting, and planning solutions. More than 1,000 hospitals in the U.S., including nine of the top 10 rated hospitals, 128 IDN systems, and 40 global academic facilities, rely on EPSi for data-driven insight into managing costs and improving their long-range financial performance. Learn more about EPSi at www.epsi.io.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2020 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Contacts

For more information, contact:
Investors:
Stephen Shulstein
312-386-6735
Stephen.Shulstein@allscripts.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com

Allscripts

NASDAQ:MDRX

Release Versions
Hashtags

Contacts

For more information, contact:
Investors:
Stephen Shulstein
312-386-6735
Stephen.Shulstein@allscripts.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com

More News From Allscripts

Veradigm Provides Business and Strategy Update

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, is providing estimated financial performance for the fiscal year 2025 and key areas of strategic focus for 2026. “On my first investor call in October, I committed to advancing three strategic objectives in my first 100 days: reset our business strategy, recover our market leadership with independent physician practices and reignite profitable growth,” said...

Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution

CHICAGO--(BUSINESS WIRE)--Veradigm (OTCMKTS:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced a new patient‑reported outcomes (PRO) survey capability that brings the patient voice directly into real‑world evidence generation. The new solution gives life sciences organizations timely, privacy‑preserving insights directly from patients, adding essential context to clinical and observational research. Built on Veradigm’s FollowMyHealth pat...

Veradigm to Release Business Update February 17th and Host Investor Call February 18th

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management plans to provide a business update after the close of regular stock market hours on February 17, 2026. Veradigm management plans to host an investor conference call and webcast to discuss the Company’s update at 8:00 a.m. Eastern Time on February 18, 2026. Update Call Details Veradigm plans to issue a press release after the c...
Back to Newsroom